Cost Variation Study of Antidiabetics: Indian Scenario

2011 ◽  
Vol 4 (5) ◽  
pp. 420-421 ◽  
Author(s):  
H. N. Lalan H. N. Lalan ◽  
◽  
Manjusha K. Borde ◽  
Ipseeta Mohanty Ray ◽  
Y. A. Deshmukh Y. A. Deshmukh
Keyword(s):  
Cost Variation ◽  
Indian Scenario

scholarly journals COST ANALYSIS OF DISEASE MODIFYING ANTI RHEUMATIC DRUGS: THE INDIAN SCENARIO

2020 ◽  
pp. 1-2
Author(s):  
Zarrin Ansari ◽  
Sharmada Nerlekar ◽  
Sagar Karia ◽  
Sudhir Pawar
Keyword(s):  
Rheumatoid Arthritis ◽  
Work Capacity ◽  
Biological Agents ◽  
Medical Specialties ◽  
Cost Variation ◽  
Conscious Choice ◽  
Socioeconomic Burden ◽  
Disease Modifying ◽  
The Cost ◽  
Indian Scenario

Background: Rheumatoid arthritis is a chronic, autoimmune and inflammatory disease affecting the joints and cartilages, eventually leading towards deformity and resultant disability. Today’s rheumatologists have an armamentarium of Disease Modifying Anti Rheumatic Drugs (DMARDs) to choose from. The chronicity of the disease, resultant deformities and reduced work capacity adds to the socioeconomic burden of the disease. This study aims to compare the costs of various brands of DMARDs (both biological and non-biological agents), so as the give the readers an idea about the cost range and variation present amongst the available DMARDs. Materials and Methods: Current Index of Medical Specialties (CIMS India) application was accessed in the month of August 2020 to note the cost of various brands of DMARDs. The information was tabulated. The cost difference and percentage cost variation was calculated and compared. Results:The maximum number of brands was available for methotrexate amongst the biological as well as non-biological agents. Least and highest percentage cost variation was observed for 2.5 mg strength of methotrexate and 100 mg of cyclosporine, respectively. In general, biologicals had fewer brands in the market as the cost was considerably higher than the non-biological agents. Conclusion:There is a wide variation amongst the costs of various DMARDs. This has its own advantages. Conscious choice of economical brands can profoundly effect the socioeconomic burden of rheumatoid arthritis management.

CSR@ 2%: A NEW MODEL OF CORPORATE SOCIAL RESPONSIBILITY IN INDIA

2018 ◽  
Vol 1 (3) ◽  
pp. 56-66
Author(s):  
Anupam Singh ◽  
Dr. Priyanka Verma
Keyword(s):  
Corporate Social Responsibility ◽  
Social Responsibility ◽  
Corporate Philanthropy ◽  
Social Issues ◽  
Business Community ◽  
Net Worth ◽  
The Social ◽  
Net Profit ◽  
Corporate Social ◽  
Indian Scenario

Corporate Social Responsibility (CSR) earlier applied as corporate philanthropy and has been in practice in India since ages. However, philanthropy in globalised and modern India does not solve the purpose in quantity and quality. Clause 135 of Company Act 2013 created huge hue and cry among the business community in India. As per clause 135 of the Companies Act, 2013, Every company with an annual turnover of 1,000 crore INR ($161 million) and more, or a net worth of 500 crore INR ($80 million) and more, or a net profit as low as five crore INR ($800,000) and more have to spend at least 2% of their average net profit over the previous three years on CSR activities. With the introduction of new Company act 2013 India became the first country in the world to have legislation for compulsory CSR spending. The paper aims at analyzing the motive of making CSR spending mandatory and it also attempts to explain the concept of CSR in the present Indian scenario, the social issues addressed by the Indian corporations, and methodologies adopted by them to address those issues.

Cost-minimization analysis of drugs used in the treatment of Asthma and COPD diseases in India

2020 ◽  
Vol 15 ◽  
Author(s):  
Billu Payal ◽  
Anoop Kumar ◽  
Harsh Saxena
Keyword(s):  
Generic Drugs ◽  
Cost Minimization ◽  
Cost Savings ◽  
Chronic Obstructive ◽  
Pulmonary Medicine ◽  
Potential Cost ◽  
Maximum Cost ◽  
Cost Minimization Analysis ◽  
Cost Variation ◽  
The Cost

Background: Asthma and Chronic Obstructive Pulmonary Diseases (COPD) are well known respiratory diseases affecting millions of peoples in India. In the market, various branded generics, as well as generic drugs, are available for their treatment and how much cost will be saved by utilizing generic medicine is still unclear among physicians. Thus, the main aim of the current investigation was to perform cost-minimization analysis of generic versus branded generic (high and low expensive) drugs and branded generic (high expensive) versus branded generic (least expensive) used in the Department of Pulmonary Medicine of Era Medical University, Lucknow for the treatment of asthma and COPD. Methodology: The current index of medical stores (CIMS) was referred for the cost of branded drugs whereas the cost of generic drugs was taken from Jan Aushadi scheme of India 2016. The percentage of cost variation particularly to Asthma and COPD regimens on substituting available generic drugs was calculated using standard formula and costs were presented in Indian Rupees (as of 2019). Results: The maximum cost variation was found between the respules budesonide high expensive branded generic versus least expensive branded generic drugs and generic versus high expensive branded generic. In combination, the maximum cost variation was observed in the montelukast and levocetirizine combination. Conclusion: In conclusion, this study inferred that substituting generic antiasthmatics and COPD drugs can bring potential cost savings in patients.

Big Data Cognitive Storage: An Optimum Way of handling the Educational Data in Indian Scenario

2017 ◽  
Vol SED2017 (01) ◽  
pp. 5-7
Author(s):  
Ruchi Jain ◽  
Neelesh Kumar Jain
Keyword(s):  
Big Data ◽  
Online Learning ◽  
Online Education ◽  
Data Protection ◽  
Teaching And Learning ◽  
Relevant Information ◽  
Indian Society ◽  
Digital Learning ◽  
Modern Education ◽  
Indian Scenario

The concept of big data has been incorporated in majority of areas. The educational sector has plethora of data especially in online education which plays a vital in modern education. Moreover digital learning which comprises of data and analytics contributes significantly to enhance teaching and learning. The key challenge for handling such data can be a costly affair. IBM has introduced the technology "Cognitive Storage" which ensures that the most relevant information is always on hand. This technology governs the incoming data, stores the data in definite media, application of levels of data protection, policies for the lifecycle and retention of different classes of data. This technology can be very beneficial for online learning in Indian scenario. This technology will be very beneficial in Indian society so as to store more information for the upliftment of the students’ knowledge.

Sign in / Sign up

Export Citation Format

Share Document